Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,776 | -66,486 | -56,070 | -27,993 | -21,732 |
| Depreciation Amortization | 12,008 | 12,623 | 2,750 | 2,983 | 4,479 |
| Accounts receivable | -3,942 | -7,041 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,232 | 1,443 | N/A | N/A | N/A |
| Other Working Capital | -6,617 | -20,187 | 6,160 | 5,150 | 789 |
| Other Operating Activity | 14,893 | 17,098 | 440 | 0 | 0 |
| Operating Cash Flow | $-38,202 | $-62,550 | $-46,720 | $-19,860 | $-16,464 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -66,132 | -1,377 | N/A | N/A | N/A |
| PPE Investments | -15,621 | -12,475 | -2,490 | -3,861 | -3,727 |
| Purchase Of Investment | -2,450 | -2,450 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 42,530 | -126,074 | -35,818 |
| Investing Cash Flow | $-84,203 | $-16,302 | $40,040 | $-129,935 | $-39,545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 241,750 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,156 | -5,320 | N/A | N/A | N/A |
| Common Stock Issued | 30,451 | 29,295 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 7,160 | 49,801 | 160,573 |
| Financing Cash Flow | $269,045 | $23,975 | $7,160 | $49,801 | $160,573 |
| Exchange Rate Effect | 3,641 | 752 | 0 | 0 | 0 |
| Beginning Cash Position | 47,011 | 101,136 | 31,990 | 131,984 | 27,420 |
| End Cash Position | 197,292 | 47,011 | 32,470 | 31,990 | 131,984 |
| Net Cash Flow | $150,281 | $-54,125 | $480 | $-99,994 | $104,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,202 | -62,550 | -46,720 | -19,860 | -16,464 |
| Capital Expenditure | -15,621 | -12,475 | N/A | N/A | N/A |
| Free Cash Flow | -53,823 | -75,025 | -46,720 | -19,860 | -16,464 |